Innoviva, Inc. (INVA)
21.06
+0.12
(+0.57%)
USD |
NASDAQ |
Oct 28, 11:27
Innoviva Price to Book Value : 1.240 for Oct. 28, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 1.233 |
| October 26, 2026 | 1.240 |
| October 23, 2026 | 1.217 |
| October 22, 2026 | 1.240 |
| October 21, 2026 | 1.232 |
| October 20, 2026 | 1.253 |
| October 19, 2026 | 1.242 |
| October 16, 2026 | 1.224 |
| October 15, 2026 | 1.229 |
| October 14, 2026 | 1.235 |
| October 13, 2026 | 1.222 |
| October 12, 2026 | 1.263 |
| October 09, 2026 | 1.249 |
| October 08, 2026 | 1.229 |
| October 07, 2026 | 1.240 |
| October 06, 2026 | 1.227 |
| October 05, 2026 | 1.216 |
| October 02, 2026 | 1.207 |
| October 01, 2026 | 1.210 |
| September 30, 2026 | 1.249 |
| September 29, 2026 | 1.243 |
| September 28, 2026 | 1.250 |
| September 25, 2026 | 1.222 |
| September 24, 2026 | 1.217 |
| September 23, 2026 | 1.192 |
| Date | Value |
|---|---|
| September 22, 2026 | 1.236 |
| September 21, 2026 | 1.239 |
| September 18, 2026 | 1.245 |
| September 17, 2026 | 1.240 |
| September 16, 2026 | 1.249 |
| September 15, 2026 | 1.227 |
| September 14, 2026 | 1.231 |
| September 11, 2026 | 1.217 |
| September 10, 2026 | 1.214 |
| September 09, 2026 | 1.244 |
| September 08, 2026 | 1.257 |
| September 04, 2026 | 1.256 |
| September 03, 2026 | 1.258 |
| September 02, 2026 | 1.258 |
| September 01, 2026 | 1.242 |
| August 31, 2026 | 1.223 |
| August 28, 2026 | 1.235 |
| August 27, 2026 | 1.234 |
| August 26, 2026 | 1.251 |
| August 25, 2026 | 1.247 |
| August 24, 2026 | 1.239 |
| August 21, 2026 | 1.241 |
| August 20, 2026 | 1.237 |
| August 19, 2026 | 1.265 |
| August 18, 2026 | 1.252 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Merck & Co., Inc. | 8.346 |
| Zevra Therapeutics, Inc. | 2.795 |
| ANI Pharmaceuticals, Inc. | 2.714 |
| Corcept Therapeutics, Inc. | 13.49 |
| Veru, Inc. | 1.364 |
Price to Book Value Related Metrics
| PE Ratio | 5.130 |
| PS Ratio | 3.811 |
| PEG Ratio | 0.0045 |
| Price to Free Cash Flow | 9.130 |
| Price | 21.06 |
| Earnings Yield | 19.49% |
| Market Cap | 1.530B |
| PEGY Ratio | 0.0045 |
| Operating PE Ratio | 10.64 |
| Normalized PE Ratio | 9.211 |